Detalhe da pesquisa
1.
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Blood
; 143(12): 1139-1156, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064663
2.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Blood
; 143(11): 1006-1017, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142424
3.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724563
4.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood
; 137(10): 1365-1376, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992344
5.
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Blood
; 141(13): 1640-1644, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450137
6.
Dark-matter matters: Discriminating subtle blood cancers using the darkest DNA.
PLoS Comput Biol
; 15(8): e1007332, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469830
7.
Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse.
Am J Hematol
; 94(10): 1091-1097, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292998
8.
Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
Br J Haematol
; 183(1): 47-59, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022491
9.
Detection of ABL1 kinase domain mutations in therapy-naïve BCR-ABL1-positive acute lymphoblastic leukemia.
Haematologica
; 107(2): 562-563, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758608
10.
Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia.
Haematologica
; 101(7): 830-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102501
11.
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
J Pathol
; 236(4): 445-56, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820993
12.
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
Int J Cancer
; 137(6): 1352-61, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25704289
13.
"Somatic" and "pathogenic" - is the classification strategy applicable in times of large-scale sequencing?
Haematologica
; 104(8): 1515-1520, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273095
14.
Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2.
Haematologica
; 103(8): e348-e350, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567772
15.
Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS.
Cytometry B Clin Cytom
; 104(2): 173-182, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088567
16.
Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS.
Blood Adv
; 7(18): 5540-5548, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505914
17.
AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
Leukemia
; 37(7): 1413-1420, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120689
18.
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Blood Adv
; 7(23): 7346-7357, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874914
19.
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Blood
; 115(22): 4497-506, 2010 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20335218
20.
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis.
Leukemia
; 36(12): 2894-2902, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261576